Entasis Therapeutics, an antibiotics developer that spun out of AstraZeneca plc in 2015, has been acquired by its majority shareholder, California’s Innoviva Inc.

Boston Biz Journal https://www.bizjournals.com/boston/news/2022/05/24/astrazeneca-spinout-based-in-waltham-acquired-at.html?ana=RSS&s=article_search